Melanoma Treatment Market Challenges, opportunities, Key Regions reports, Drivers, key segment and Company Forecast 2018 – 2026

                                                                              
Melanoma is a disorder in which melanocytes develop malignant (cancer) cells (cells that colour the skin).

          Melanoma Treatment Market



Melanoma is a disorder in which melanocytes develop malignant (cancer) cells (cells that colour the skin). There are a variety of cancers that begin in the skin. Melanoma can develop anywhere on the body's surface. Melanoma risk is influenced by unusual moles, sun exposure, and medical history.


Melanoma can be treated with surgery, radiation therapy, and medication. Different types of medicines are available on the market, including adjuvant therapy, immunotherapy, and chemotherapy. Due to an increase in the prevalence of melanoma and improvements in healthcare facilities, the global Melanoma Treatment Market is growing at a rapid pace. Furthermore, government initiatives and technological breakthroughs propel the melanoma treatment market forward.


Several medications on the market have previously been approved by the FDA for the treatment of melanoma, and others are in the works. For the treatment of cutaneous melanoma, drugs such as Polynoma's seviprotimut-L, Amgen Inc.'s talimogene laherparepvec (T-VEC), and Roche and Genetech's zelboraf are being developed. AstraZeneca is developing selumetinib for the treatment of ocular melanoma. Bristol-Myers Squibb developed Yervoy, a monoclonal antibody medication, for the treatment of melanoma in 2011, and it was the first drug to earn FDA clearance. Opdivo and keytruda are immunotherapy medications that have been approved by the FDA and have offered new options in the melanoma treatment market.


Market Segmentation:

By Melanoma Type

  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Ocular Melanoma

By Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Surgical Treatment
  • Pharmacological Treatment

Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company.




Comments

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Anti-Epileptic Drugs Market By Spectrum Type, By Drug and Geography – Opportunities & Forecast 2027 | Novartis AG, GlaxoSmithKline Plc, Johnson & Johnson Service, Inc., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Zogenix, Dr. Reddy's Laboratories Ltd. And Alkem Labs

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027